BioStem Technologies, Inc. (BSEM) Tops Q1 EPS by 3c

BioStem Technologies, Inc. (OTC: BSEM) reported Q1 EPS of $0.20, $0.03 better than the analyst estimate of $0.17. Revenue for the quarter came in at $41.9 million versus the consensus estimate of $13.1 million.

For earnings history and earnings-related data on BioStem Technologies, Inc. (BSEM) click here.

You May Also Be Interested In

• The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
• Freedom Broker Upgrades Morgan Stanley (MS) to Buy
• Oppenheimer upgrades Ecolab to Outperform, sees AI growth driving upside